These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2967472

  • 41. Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage.
    Lucek RW, Dickerson J, Carter DE, Bugge CJ, Crews T, Vane FM, Cunningham W, Colburn WA.
    Biopharm Drug Dispos; 1988; 9(5):487-99. PubMed ID: 3066416
    [Abstract] [Full Text] [Related]

  • 42. Systemic retinoid therapy for psoriasis.
    Lowe NJ, Lazarus V, Matt L.
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD, Kim HK, Kim JW, Kim DW, Lee JH, Huh W, Youn JI, Kim HG, Kim YG, Kim MH, Lee SY.
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [Abstract] [Full Text] [Related]

  • 44. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
    Ruzicka T, Meurer M, Bieber T.
    Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
    [Abstract] [Full Text] [Related]

  • 45. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
    Löfberg B, Chahoud I, Bochert G, Nau H.
    Teratology; 1990 Jun; 41(6):707-16. PubMed ID: 2141193
    [Abstract] [Full Text] [Related]

  • 46. The retinoids. A review of their clinical pharmacology and therapeutic use.
    Orfanos CE, Ehlert R, Gollnick H.
    Drugs; 1987 Oct; 34(4):459-503. PubMed ID: 3315625
    [Abstract] [Full Text] [Related]

  • 47. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
    Thongnopnua P, Zimmerman CL.
    J Chromatogr; 1988 Dec 09; 433():345-51. PubMed ID: 2976770
    [No Abstract] [Full Text] [Related]

  • 48. Side-effect profile of acitretin therapy in psoriasis.
    Gupta AK, Goldfarb MT, Ellis CN, Voorhees JJ.
    J Am Acad Dermatol; 1989 Jun 09; 20(6):1088-93. PubMed ID: 2526824
    [Abstract] [Full Text] [Related]

  • 49. [Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy].
    Almond-Roesler B, Orfanos CE.
    Hautarzt; 1996 Mar 09; 47(3):173-7. PubMed ID: 8647698
    [Abstract] [Full Text] [Related]

  • 50. Acitretin improves psoriasis in a dose-dependent fashion.
    Goldfarb MT, Ellis CN, Gupta AK, Tincoff T, Hamilton TA, Voorhees JJ.
    J Am Acad Dermatol; 1988 Apr 09; 18(4 Pt 1):655-62. PubMed ID: 2967310
    [Abstract] [Full Text] [Related]

  • 51. Etretinate kinetics during chronic dosing in severe psoriasis.
    Massarella J, Vane F, Buggé C, Rodriguez L, Cunningham WJ, Franz T, Colburn W.
    Clin Pharmacol Ther; 1985 Apr 09; 37(4):439-46. PubMed ID: 3979005
    [Abstract] [Full Text] [Related]

  • 52. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG.
    Acta Derm Venereol Suppl (Stockh); 1994 Apr 09; 190():1-33. PubMed ID: 7900497
    [No Abstract] [Full Text] [Related]

  • 53. The antipsoriatic drug metabolite etretin (Ro 10-1670) alters the metabolism of fatty acids in human keratinocytes in culture.
    Punnonen K, Puustinen T, Jansén CT.
    Arch Dermatol Res; 1988 Apr 09; 280(2):103-7. PubMed ID: 2456041
    [Abstract] [Full Text] [Related]

  • 54. Use of retinoids in the treatment of psoriasis.
    Warren EW, Khanderia U.
    Clin Pharm; 1989 May 09; 8(5):344-51. PubMed ID: 2663325
    [Abstract] [Full Text] [Related]

  • 55. Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
    Bouvy ML, Sturkenboom MC, Cornel MC, De Jong-Van den Berg LT, Stricker BH, Wesseling H.
    Pharm Weekbl Sci; 1992 Apr 24; 14(2):33-7. PubMed ID: 1388261
    [Abstract] [Full Text] [Related]

  • 56. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis.
    Olsen EA, Weed WW, Meyer CJ, Cobo LM.
    J Am Acad Dermatol; 1989 Oct 24; 21(4 Pt 1):681-6. PubMed ID: 2530251
    [Abstract] [Full Text] [Related]

  • 57. In vitro embryotoxicity and teratogenic potential of etretinate and etretin.
    Bechter R, Hall L.
    Toxicol In Vitro; 1987 Oct 24; 1(4):225-31. PubMed ID: 20702367
    [Abstract] [Full Text] [Related]

  • 58. Etretinate: effect of milk intake on absorption.
    DiGiovanna JJ, Gross EG, McClean SW, Ruddel ME, Gantt G, Peck GL.
    J Invest Dermatol; 1984 Jun 24; 82(6):636-40. PubMed ID: 6233379
    [Abstract] [Full Text] [Related]

  • 59. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
    Brazzell RK, Colburn WA.
    J Am Acad Dermatol; 1982 Apr 24; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675
    [Abstract] [Full Text] [Related]

  • 60. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
    Moy RL, Kingston TP, Lowe NJ.
    Arch Dermatol; 1985 Oct 24; 121(10):1297-301. PubMed ID: 3862363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.